Burry's Consultant Critique Adds Fuel to Palantir's Backlog Conversion Concerns

What happened

The Motley Fool article highlights Michael Burry's comment that Palantir's receivables resemble a consultant's, pointing to accounts receivable rising to $1.49B at end of June, up from $1.04B at end of 2025, with one customer representing 27% of AR. This aligns with our existing early warning indicator that AR concentration stays elevated while total AR continues rising, signaling collections and program timing are becoming more concentrated. The master report already flagged that no customer exceeds 10% of revenue, but AR concentration matters because it risks cash conversion if large programs delay payments. Palantir's broader issue remains conversion of soft bookings into hard revenue visibility, with company-wide RPO at $4.9B and 43% due in 12 months, while TCV/RDV growth outpaces deferred revenue and customer deposits. Thus, Burry's observation reinforces the WAIT rating, as the stock's premium valuation at 147.6x P/E leaves no room for further receivables deterioration or slower collections.

Implication

The AR jump to $1.49B and 27% concentration from one customer underscore that Palantir's revenue growth is increasingly dependent on a few large programs, which could delay cash collections and signal weaker revenue quality. While no customer exceeds 10% of revenue, the receivables spike suggests either aggressive revenue recognition or extended payment terms, both of which raise the risk of future write-offs or renegotiations. Combined with the already identified gap between TCV/RDV and RPO, this supports the thesis that the market may be capitalizing soft bookings rather than durable revenue visibility. Near-term catalysts to watch include the next quarterly filing's RPO, deferred revenue, and customer deposits, as well as any changes in AR aging or concentration disclosures. Until these metrics improve, the stock's valuation leaves little margin for error, and we maintain a WAIT rating with a preferred entry near $155.

Thesis delta

The WAIT thesis is unchanged. Burry's comment does not introduce a new fundamental risk but amplifies the existing concern about receivables quality and concentration. It strengthens the case for monitoring cash conversion and backlog quality before considering entry.